C-UCM and Cerebral Oxygenation and Perfusion
Primary Purpose
Preterm Infant, Term Infant, Transition
Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Intervention Group
Control Group
Sponsored by

About this trial
This is an interventional diagnostic trial for Preterm Infant
Eligibility Criteria
Inclusion Criteria:
- Neonates with a gestational age ≥28 weeks
- Delivered by caesarean section
- Decision to conduct full life support
- Written informed consent prior to birth
Exclusion Criteria:
- Neonates with a gestational age <28 weeks
- No decision to conduct full life support
- No written informed consent
- Severe congenital malformations
Sites / Locations
- Dep. of Pediatrics, Medical University of Graz
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Intervention Group
Control Group
Arm Description
Milking the cut umbilical cord once towards the Infant at a speed of 10cm/second.
The umbilical cord is cut according to the standard procedure and no C-UCM is performed.
Outcomes
Primary Outcome Measures
Cerebral blood volume
Changes in CBV (ml/100g brain)
Secondary Outcome Measures
Cerebral tissue oxygenation index
Changes in cTOI (%)
Peripheral oxygen saturation
Changes in SpO2 (%)
Heart rate
Changes in HR (beats per minute)
Stroke volume
Changes in SV (ml)
Cardiac output
Changes in CO (l/min)
Mean arterial blood pressure
Changes in MABP (mmHg)
Full Information
NCT ID
NCT03748914
First Posted
November 14, 2018
Last Updated
March 15, 2021
Sponsor
Medical University of Graz
1. Study Identification
Unique Protocol Identification Number
NCT03748914
Brief Title
C-UCM and Cerebral Oxygenation and Perfusion
Official Title
The Influence of Cut-umbilical Cord Milking (C-UCM) on the Cerebral Oxygenation and Perfusion of Preterm and Term Infants
Study Type
Interventional
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
November 21, 2018 (Actual)
Primary Completion Date
November 18, 2019 (Actual)
Study Completion Date
November 18, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical University of Graz
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this randomized controlled Pilot study the effects of cut-umbilical cord milking on cerebral oxygenation and perfusion measured via near-infrared spectroscopy (NIRS) and the effects on stroke volume (SV) and cardiac output (CO) also measured non-invasively in term and preterm infants are evaluated for the first 15 minutes after birth and compared to a control group.
Detailed Description
Background
The transition to life after birth is a complex physiological process where the neonate has to establish sufficient ventilation and changes from intra-uterine circulation to extra-uterine circulation take place. During these processes the neonate has to provide the brain with adequate perfusion and oxygen delivery to maintain normal cerebral tissue oxygenation and activity. Instability of cerebral perfusion and oxygenation may be associated with brain damage in preterm infants. The concept of C-UCM may substitute the adverse effects of immediate cord clamping by supplying additional placental blood to the infant, which is mostly performed during caesarean section or in the critically ill neonate.
In this randomized controlled Pilot study the effects of cut-umbilical cord milking on cerebral oxygenation and perfusion measured via near-infrared spectroscopy (NIRS) and the effects on stroke volume (SV) and cardiac output (CO) also measured non-invasively in term and preterm infants are evaluated for the first 15 minutes after birth and compared to a control group.
Aim
The aim of the study is to analyse whether C-UCM in preterm and term infants results in an improvement of cerebral oxygenation and perfusion during immediate neonatal transition measured with NIRS.
Hypotheses
Infants undergoing C-UCM after birth compared to infants without C-UCM show differences in cerebral oxygenation and perfusion in the first 15 min after birth.
Hypothesis I: C-UCM and cerebral blood volume (CBV) In infants with C-UCM there is more CBV decrease immediately after birth, compared to infants without C-UCM, due to improved cerebral oxygen delivery.
Hypothesis II: C-UCM and cerebral regional oxygen saturation (crSO2) Infants with C-UCM have higher crSO2 values during immediate neonatal transition, compared to infants without C-UCM, again due to improved cerebral oxygen delivery.
Hypothesis III: C-UCM and stroke volume (SV) In infants with C-UCM the SV at 15 minutes after birth is higher, compared to infants without C-UCM
Hypothesis IV: C-UCM and cardiac output (CO) In infants with C-UCM the CO at 15 minutes after birth is higher, compared to infants without C-UCM.
Hypothesis V: C-UCM and mean arterial blood pressure (MABP) In infants with C-UCM the MABP at 5, 10 and 15 minutes after birth is higher, compared to infants without C-UCM.
Study population
Preterm infants Neonates with a gestational age ≥28 - 37 weeks delivered by caesarean section at the Department of Obstetrics and Gynaecology, Medical University of Graz, will be enrolled into the study, provided written informed consent is obtained from parents prior to birth. Neonates with severe congenital malformations will be excluded.
Term Infants Neonates with a gestational age ≥37 weeks delivered by caesarean section at the Department of Obstetrics and Gynaecology, Medical University of Graz, will be enrolled into the study, provided written informed consent is obtained from parents prior to birth. Neonates with severe congenital malformations will be excluded.
Study design
The present study is designed as a randomized controlled pilot trial. As there have not been prior human studies investigating C-UCM regarding the outcome measures cerebral oxygenation and perfusion, a randomized controlled pilot study is the appropriate first step to be able to calculate sample size for a bigger trial.
Sample Size
Sample size calculations were not performed, since there are no data from previous human studies available, and this pilot study needs to be conducted to generate data for the sample size calculation of a consecutive main study. For this pilot study a sample size of 80 infants (20 subjects in the intervention group of preterm infants, 20 subjects in the intervention group of term infants, 20 subjects in each of the two control groups) is arbitrary designated.
Procedure
The medical history focussing on any pathologic findings during pregnancy and delivery will be collected and stored anonymously.
After delivery of the neonate via caesarean section, in the intervention group the umbilical cord will be clamped within 30 seconds and cut long at least 30 cm by the obstetrician. The neonate is then placed under an overhead heater by the midwife. There, the umbilical cord must be untwisted and held in a vertical position. It is milked once by the neonatologist towards the baby at a speed of approximately 10 cm/s and then clamped 3 cm from the umbilicus by one member of the clinical team. In contrast, in the control group the umbilical cord is cut according to the standard procedure and no C-UCM is performed. The further treatment procedure is the same in both groups.
A NIRS transducer will be placed on the newborn's left forehead, and fixed with a modified neonatal CPAP cap or gauze bandage by a scientific staff member without disturbing routine medical care. Furthermore, a pulse oximeter sensor will be attached on the right wrist or palm to monitor preductal oxygen saturation by pulse oximetry (SpO2) and heart rate (HR). Moreover 4 electrodes are fixed on the skin for the non-invasive cardiac output monitoring (NICOM) to evaluate SV and CO. All the measurements will be performed within the first 15 minutes after birth.
Intervention The pneumatic cuff for the oscillometric measurements of the arterial blood pressure will be placed around the left upper arm (or alternatively on the left lower leg) at 5, 10 and 15 minutes after birth. A capillary blood gas check 15 minutes after birth will be performed in all the patients; However infants in need for respiratory support during postnatal stabilisation receive this blood gas check routinely. Moreover, rectal temperature will be measured at 15 minutes after birth.
A stopwatch is started at delivery, the time points of umbilical cord clamping, C-UCM in the intervention group, establishment of NIRS measurement, establishment of SpO2 measurement, and blood drawing for the gas check will be noted.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Infant, Term Infant, Transition
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
Milking the cut umbilical cord once towards the Infant at a speed of 10cm/second.
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
The umbilical cord is cut according to the standard procedure and no C-UCM is performed.
Intervention Type
Other
Intervention Name(s)
Intervention Group
Other Intervention Name(s)
Cut umbilical cord milking (C-UCM)
Intervention Description
After delivery of the neonate via caesarean section the umbilical cord will be clamped within 30 seconds and cut long at least 30 cm by the obstetrician. The neonate is then placed under an overhead heater by the midwife. There, the umbilical cord must be untwisted and held in a vertical position. It is milked once by the neonatologist towards the baby at a speed of approximately 10 cm/s and then clamped 3 cm from the umbilicus by one member of the clinical team.
Intervention Type
Other
Intervention Name(s)
Control Group
Other Intervention Name(s)
Standard care
Intervention Description
The umbilical cord is cut according to the standard procedure and no C-UCM is performed.
Primary Outcome Measure Information:
Title
Cerebral blood volume
Description
Changes in CBV (ml/100g brain)
Time Frame
within the first 15 minutes after birth.
Secondary Outcome Measure Information:
Title
Cerebral tissue oxygenation index
Description
Changes in cTOI (%)
Time Frame
within the first 15 minutes after birth
Title
Peripheral oxygen saturation
Description
Changes in SpO2 (%)
Time Frame
within the first 15 minutes after birth
Title
Heart rate
Description
Changes in HR (beats per minute)
Time Frame
within the first 15 minutes after birth
Title
Stroke volume
Description
Changes in SV (ml)
Time Frame
within the first 15 minutes after birth
Title
Cardiac output
Description
Changes in CO (l/min)
Time Frame
within the first 15 minutes after birth
Title
Mean arterial blood pressure
Description
Changes in MABP (mmHg)
Time Frame
within the first 15 minutes after birth
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Minute
Maximum Age & Unit of Time
15 Minutes
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Neonates with a gestational age ≥28 weeks
Delivered by caesarean section
Decision to conduct full life support
Written informed consent prior to birth
Exclusion Criteria:
Neonates with a gestational age <28 weeks
No decision to conduct full life support
No written informed consent
Severe congenital malformations
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Berndt Urlesberger, Professor
Organizational Affiliation
Division of Neonatology, Medical University of Graz
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dep. of Pediatrics, Medical University of Graz
City
Graz
State/Province
Styria
ZIP/Postal Code
8036
Country
Austria
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
C-UCM and Cerebral Oxygenation and Perfusion
We'll reach out to this number within 24 hrs